Safety & efficacy assessment of products on ski
Not Applicable
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2020/02/023151
- Lead Sponsor
- aCorium Health International Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects should have psoriasis affecting <20% of Body Surface Area.
Exclusion Criteria
For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
Having refused to give his/her assent by signing the consent form
Taking part in another study liable to interfere with this study
Having history of cutaneous hypersensitivity
Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
Ongoing use prohibited treatments (e.g. topical corticosteroids at least seven days on test site, systemic corticosteroids, oral anti psoriatic medication & Phototherapy at least four weeks.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety & Efficacy assessment of productsTimepoint: T0, T7 days, T14 days & T28 days
- Secondary Outcome Measures
Name Time Method SafetyTimepoint: T0 days,T7 days, T14 days, T28 days